Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels-Reference-Cited by-同舟云学术

Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels

Published:2012-11 Issue:19 Volume:60 Page:1888-1898
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Dias Clapton S.,Shaywitz Adam J.,Wasserman Scott M.,Smith Brian P.,Gao Bing,Stolman Dina S.,Crispino Caroline P.,Smirnakis Karen V.,Emery Maurice G.,Colbert Alexander,Gibbs John P.,Retter Marc W.,Cooke Blaire P.,Uy Stephen T.,Matson Mark,Stein Evan A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines;Grundy;Circulation,2004

2. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report;Circulation,2002

3. Inhibition of PCSK9: a powerful weapon for achieving ideal LDL cholesterol levels;Steinberg;Proc Natl Acad Sci U S A,2009

4. PCSK9: a convertase that coordinates LDL catabolism;Horton;J Lipid Res,2009

5. Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis;Qian;J Lipid Res,2007

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel drug design and repurposing: An opportunity to improve translational research in cardiovascular diseases?;Archiv der Pharmazie;2024-07-29

2. Cholesterol reduction by immunization with a PCSK9 mimic;Cell Reports;2024-06

3. Effect of evolocumab on carotid plaque composition in asymptomatic carotid artery stenosis (EVOCAR-1) using magnetic resonance imaging;Journal of Clinical Lipidology;2024-06

4. Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy;Atherosclerosis;2024-05

5. Efficacy and Safety of Inclisiran, Alirocumab, Evolocumab, and Evinacumab in Lipid-Lowering: A Network Meta-Analysis;2024-04-17